Home > Balance Sheet > BIOCON

BIOCON
Capital Work in Progress

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Capital Work in Progress ₹4,613 Cr₹4,102 Cr₹3,985 Cr₹2,588 Cr₹3,420 Cr

What is the latest Capital Work in Progress ratio of BIOCON ?

The latest Capital Work in Progress ratio of BIOCON is ₹4,613 Cr based on Mar2026 Consolidated results.
Year Capital Work in Progress
Mar2026₹4,613 Cr
Mar2025₹4,102 Cr
Mar2024₹3,985 Cr
Mar2023₹2,588 Cr
Mar2022₹3,420 Cr

How is Capital Work in Progress of BIOCON Trending?

Years Capital Work in Progress % Change
Mar2026 ₹4,613 Cr
12.46
Mar2025 ₹4,102 Cr
2.92
Mar2024 ₹3,985 Cr
54.02
Mar2023 ₹2,588 Cr
-24.35
Mar2022 ₹3,420 Cr -

Compare Capital Work in Progress of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹62,743.5 Cr -1.5% -7.1% 4.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.5%

-7.1%

4.1%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses